Magenta Therapeutics, Inc.
METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Last updated:

Abstract:

Described herein are compositions and methods useful for the depletion of CD117+ or CD45+ cells and for the treatment of various hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, among others. The compositions and methods described herein can be used to treat a disorder, for instance, by depleting a population of CD117+ or CD45+ cancer cells or autoimmune cells. The compositions and methods described herein can also be used to prepare a patient for allogeneic hematopoietic stem cell transplant therapy and to improve the engraftment of allogeneic hematopoietic stem cell transplants by selectively depleting endogenous hematopoietic stem cells prior to the transplant procedure.

Status:
Application
Type:

Utility

Filling date:

29 Apr 2021

Issue date:

9 Dec 2021